Evidence map›Paper›PMID 26692377›Full record

ArticleJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics2016

Differentiation of Induced Pluripotent Stem Cells to Neural Retinal Precursor Cells on Porous Poly-Lactic-co-Glycolic Acid Scaffolds.

Kristan S Worthington, Luke A Wiley, C Allan Guymon, Aliasger K Salem, Budd A Tucker

Open access · greenAbstract read
In one paragraph

Article in Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Kristan S Worthington1 Department of Ophthalmology and Visual Sciences, Wynn Institute for Vision Research, The University of Iowa , Iowa City, Iowa.
Luke A Wiley1 Department of Ophthalmology and Visual Sciences, Wynn Institute for Vision Research, The University of Iowa , Iowa City, Iowa.
C Allan Guymon2 Department of Chemical and Biochemical Engineering, The University of Iowa , Iowa City, Iowa.
Aliasger K Salem3 Division of Pharmaceutics and Translational Therapeutics, Department of Pharmaceutical Sciences and Experimental Therapeutics, The University of Iowa , Iowa City, Iowa.
Budd A Tucker1 Department of Ophthalmology and Visual Sciences, Wynn Institute for Vision Research, The University of Iowa , Iowa City, Iowa.
University of Iowa · US

Funding

Development of a cell replacement therapy to treat retinal degenerative blindnessDP2OD007483 · OD · UNIVERSITY OF IOWA · PI TUCKER, BUDD A · 2010 to 2010
$2.3M
FUNDS TO ACQUIRE A JEOL JSM-7401F FESEM: LUNGS10RR022498 · NCRR · UNIVERSITY OF IOWA · PI APICELLA, MICHAEL A. · 2006 to 2006
$445k
NCRR NIH HHS S10 RR022498NIH HHS DP2 OD007483
6 · The paper itself

Abstract

purposeCell replacement therapy for the treatment of retinal degeneration is an increasingly feasible approach, but one that still requires optimization of the transplantation strategy. To this end, various polymer substrates can increase cell survival and integration, although the effect of their pore size on cell behavior, particularly differentiation, has yet to be explored.

methodsSalt crystals of varying known size were used to impart structure to poly(lactic-co-glycolic acid) (PLGA) scaffolds by a salt leaching/solvent evaporation process. Mouse induced pluripotent stem cells (miPSCs) were seeded to the polymer scaffolds and supplemented with retinal differentiation media for up to 2 weeks. Proliferation was measured during the course of 2 weeks, while differentiation was evaluated using cell morphology and expression of early retinal development markers.

resultsThe salt leaching method of porous PLGA fabrication resulted in amorphous smooth pores. Cells attached to these scaffolds and proliferated, reaching a maximum cell number at 10 days postseeding that was 5 times higher on porous PLGA than on nonporous controls. The morphology of many of these cells, including their formation of neurites, was suggestive of neural phenotypes, while their expression of Sox2, Pax6, and Otx2 indicates early retinal development.

conclusionsThe use of porous PLGA scaffolds to differentiate iPSCs to retinal phenotypes is a feasible pretransplantation approach. This adds to an important knowledge base; understanding how developing retinal cells interact with polymer substrates with varying structure is a crucial component of optimizing cell therapy strategies.

Indexed as

Cell DifferentiationAnimalsCell CountCell ProliferationCells, CulturedInduced Pluripotent Stem CellsLactic AcidMicePolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerPorosityRetinaSodium ChlorideLactic AcidPolyglycolic AcidPolylactic Acid-Polyglycolic Acid CopolymerSodium Chloride

Identifiers

PMID26692377
PMCPMC4904232
OpenAlexW2219143930

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.